Not sure if they are on track. These were the goals for Q1 of 2022 released in updated Presentation on 3/2/22:
- EXO-NET collaborations (AU)
- Feasibility results for SubB2M immunoassay for breast cancer
- Manufacturing agreement for SubB2M
- SubB2M publication (breast cancer)
Still a couple of days left in Q1 2022, but haven't heard of progress on any of the goals for the quarter? Hopefully we'll hear soon but not looking promising.
Not sure if they are on track. These were the goals for Q1 of...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 58.0¢ | $4.527K | 7.767K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38600 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 198 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |